bioRxivMicrobiologyPreprint
Phosphatidylserine receptors are critical for lethal infection by Crimean-Congo hemorrhagic fever virus
Jacob L. BerriganiD, Stephanie R. MonticelliiD, Matt Daileg RamireziD, Paige T. Donovan, Taylor S. Powell, Ana I. Kuehne, Russell R. BakkeniD, Sarah B. SulkoskyiD, Susan Rajnik CoyneiD, Kevin Xiankun ZengiD, Christopher P. StefaniD, Andrew S. HerbertiD, Wendy J. MauryiD, Kartik ChandraniD, Ezgi KaşıkcıiD
Abstract
The tick-borne Crimean-Congo hemorrhagic fever virus (CCHFV) causes severe and often fatal hemorrhagic disease for which no approved countermeasures are available. Herein, we identify the phosphatidylserine receptors (PSRs) AXL, TIM-1, and TIM-4 as critical entry host factors for CCHFV in cell lines and liver-derived primary cell cultures. Small-molecule and antibody-based PSR inhibitors greatly reduced viral infection in cell culture. Germline knockout of individual PSR genes afforded partial protection against CCHFV infection, disease, and death in a murine model of lethal viral challenge. Mice engineered to lack two PSRs were completely protected from challenge, with viremia and viral replication, pathology, and inflammation in the liver and spleen reduced to baseline. Therefore, PSRs are collectively indispensable for CCHFV infection and pathogenesis. We conclude that PSRs are not just cell entry factors but bona fide determinants of infection, dissemination, and disease by CCHFV and legitimate targets for the development of new antiviral countermeasures.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Phosphatidylserine within the Viral Membrane Enhances Chikungunya Virus Infectivity in a Cell-type Dependent Manner
K. L. Miazgowicz, J. M. Reyes Ballista, … M. A. Brindley·bioRxiv·Jan 14, 2022
- Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread
Felix Pahmeier, Stephanie R. Monticelli, … Eva Harris·Science Translational MedicinePeer-reviewed·Feb 19, 2025
- A single-dose recombinant rVSVΔG-CCHFV-GPC vaccine protects nonhuman primates against heterologous Crimean-Congo hemorrhagic fever virus challenge
Robert W. Cross, Kevin Melody, … Thomas W. Geisbert·bioRxiv·Oct 22, 2026
- Distinguishing host responses, extensive viral dissemination and long-term viral RNA persistence in domestic sheep experimentally infected with Crimean-Congo hemorrhagic fever virus Kosovo Hoti
H. Li, M. Pinette, … B. Pickering·bioRxiv·Aug 4, 2023
- The single amino acid change of R516K enables efficient generation of vesicular stomatitis virus-based Crimean-Congo hemorrhagic fever reporter virus
Xue Ma, Yanlong Ma, … Rong Zhang·Journal of Medical VirologyPeer-reviewed·Jun 1, 2025
- Characterization of a lethal Crimean-Congo hemorrhagic fever virus infection model in interferon-deficient mice for studies of virus pathogenicity and vaccine efficacy
Andrei E. Siniavin, Anna A. Iliukhina, … Vladimir А. Gushchin·bioRxiv·Dec 23, 2025